In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to end the shortened week on a positive note. At the time of writing, the benchmark index is up 0.6% to 6,680.9 points.
Four shares that have failed to follow the market higher today are listed below. Here’s why they are dropping lower:
Mesoblast limited (ASX: MSB)
The Mesoblast share price is down almost 1% to $2.34. This is despite there being no news out of the biotech company today. However, its shares have been extremely volatile recently after revealing disappointing results from two key studies.
Monash IVF Group Ltd (ASX: MVF)
The Monash IVF share price has tumbled 4% lower to 76 cents. Investors have been selling the fertility treatment company’s shares after it revealed that proceedings have been filed against it in the Supreme Court of Victoria. These proceedings are in relation to the company’s non-invasive preimplantation genetic screening technology. The claim does not specify an amount of damages sought.
Netwealth Group Ltd (ASX: NWL)
The Netwealth share price has fallen almost 3% to $15.94. Investors have been selling the investment platform provider’s shares despite there being no news out of it. However, with its shares up over 100% since the start of the year, this decline could be due to profit taking from some investors.
Reece Ltd (ASX: REH)
The Reece share price is down 1.5% to $14.85. Once again, this is despite there being no news out of the plumbing parts company today. Though, prior to today the company’s shares were up strongly over the space of the month. This was driven partly by the company’s inclusion in the ASX 200 index at the quarterly rebalance. Reece joined the illustrious index on Monday.
This Tiny ASX Stock Could Be the Next Afterpay
One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…
Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.
Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!
See how you can find out the name of this stock
Returns as of 6th October 2020
More reading
- ASX 200 up 0.5%: BHP Samarco update, A2 Milk’s acquisition, Credit Corp rockets
- Why a2 Milk, Air New Zealand, Mesoblast, & Recce shares are storming higher
- 7 top ASX biomedical shares in 2020
- Why AGL, Mesoblast, WiseTech, & Woodside are dropping lower
- Why Elixinol Global, Flight Centre, Mesoblast, & WiseTech shares are dropping lower
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Netwealth. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post Why Mesoblast, Monash IVF, Netwealth, & Reece shares are dropping lower appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/37MseIw
Leave a Reply